PX1 Research is a dedicated USA supplier of research-grade Cortagen (Ala-Glu-Asp-Pro), formulated specifically for laboratory investigation into neurodegenerative mechanisms, cellular aging, and central nervous system repair pathways. Every lot undergoes independent ISO 17025 HPLC and mass spectrometry verification to guarantee >98% purity, strict endotoxin controls, and batch-to-batch consistency for academic and biotech institutions.
PX1 Research is a dedicated USA supplier of research-grade Cortagen (Ala-Glu-Asp-Pro), formulated specifically for laboratory investigation into neurodegenerative mechanisms, cellular aging, and central nervous system repair pathways. Every lot undergoes independent ISO 17025 HPLC and mass spectrometry verification to guarantee >98% purity, strict endotoxin controls, and batch-to-batch consistency for academic and biotech institutions.
When purchasing Cortagen for preclinical research into neurodegenerative disease models, laboratory investigators require absolute analytical transparency, strict lot-to-lot consistency, and verifiable purity. Cortagen is a synthetic short-chain bioregulatory peptide comprised of four amino acid residues (Ala-Glu-Asp-Pro) engineered to mimic endogenous cortex-derived peptide complexes. In laboratory models, this compound is evaluated for its interactions with neuronal chromatin structure, gene expression cascades, and cellular survival mechanisms following metabolic or oxidative stress.
PX1 Research operates as a primary USA-based supplier supplying high-purity research compounds to academic laboratories, pharmaceutical research organizations, and biotechnology facilities. Investigators seeking to buy neurodegenerative disease research Cortagen supplier materials receive fully characterized, lyophilized peptides backed by complete analytical documentation. Browse our comprehensive catalog of all peptides or inspect specific chemical profiles in our dedicated research library to support your ongoing experimental protocols.
Cortagen is classified within the bioregulatory class of short peptides, defined by its specific amino acid sequence: L-alanyl-L-glutamyl-L-alpha-aspartyl-L-proline ($C_{17}H_{26}N_{4}O_{9}$, MW: 430.41 g/mol). Structurally, its low molecular mass enables rapid diffusion across experimental membrane barriers during in vitro cellular assays and rodent organotypic tissue slice cultures. The structural design relies on the alternating hydrophobic and polar side chains of alanine, glutamic acid, aspartic acid, and proline, which facilitate localized electrostatic interactions with nucleosomal DNA and histones.
Unlike complex recombinant proteins that suffer from variable folding states and post-translational heterogeneity, synthetic Cortagen synthesized via solid-phase peptide synthesis (SPPS) yields a homogenous chemical entity. This structural simplicity reduces analytical noise during HPLC assay development and mass spectrometry identification, making Cortagen an ideal benchmark molecule for investigating short-peptide nuclear penetration and transcriptomic regulation in neural cell lineages.
In vitro and animal model data indicate that Cortagen exerts its primary physiological effects through direct interaction with the genomic apparatus of neural cells. Preclinical studies suggest that short bioregulatory peptides like Cortagen penetrate cell membranes and nuclear envelopes, selectively binding to specific histone protein regions and canonical promoter sequences. This physical association appears to alter local chromatin conformation from heterochromatin to euchromatin, thereby promoting the transcriptional activation of genes associated with neuronal survival, structural repair, and antioxidant defense.
Specifically, in models of acute ischemic injury and chronic neurodegeneration, Cortagen administration has been shown to downregulate pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-$\alpha$). Concurrently, in vitro assays demonstrate an upregulation of neurotrophic factors and anti-apoptotic signaling pathways, including Bcl-2 expression. By attenuating caspase-3 activation and reducing reactive oxygen species (ROS) accumulation, Cortagen serves as a critical candidate for investigating molecular interventions in motor neuron preservation and cerebral cortex remodeling.
To properly contextualize Cortagen within CNS bioregulatory research, investigators frequently compare its functional spectrum against other synthetic short peptides and neuroprotective agents targeting similar pathways. While Cortagen specifically targets cortical cell gene expression and neuro-inflammatory cascades, related peptides engage distinct receptor mechanisms or target non-cortical tissue types.
For example, Pinealon is a tripeptide (Glu-Asp-Arg) evaluated primarily for its impact on circadian regulation, ROS scavenging, and cerebellar/hippocampal protection under hypoxemic stress. Meanwhile, Epitalon (Ala-Glu-Asp-Gly) demonstrates widespread telomerase-modulating activity in somatic and endocrine cell lines, contrasting with Cortagen's specialized activity in neural cell differentiation and repair. Additionally, non-bioregulatory neuroactive compounds like Semax operate via brain-derived neurotrophic factor (BDNF) elevation and tropomyosin receptor kinase B (TrkB) signaling rather than direct nuclear DNA binding. Combining these distinct peptide classes allows researchers to map complementary pathways in cellular neurodegenerative models.
Research integrity depends on compound purity. Low-grade synthesis impurities, residual organic solvents (such as TFA or DMF), and truncated peptide sequences can corrupt cell viability assays, induce non-specific cytotoxicity, and yield irreproducible transcriptomic data.PX1 Research enforces strict quality control standards for every production lot destined for research applications.
Each batch of Cortagen undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity ($>98\%$) and electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular weight match. Furthermore, all lots undergo quantitative Chromogenic Recombinant Factor C (rFC) testing to confirm endotoxin levels remain below $<0.05\text{ EU/mg}$. Independent ISO 17025 accredited laboratories perform these tests, and full Certificates of Analysis (COAs) are published openly for investigator verification before purchase.
Cortagen is supplied as a sterile, lyophilized (freeze-dried) powder in sealed borosilicate glass vials to ensure long-term stability. To maintain compound integrity during in vitro or preclinical animal studies, laboratory personnel must follow standard aseptic reconstitution procedures inside a laminar flow hood.
For most cellular assays, lyophilized Cortagen should be reconstituted using sterile, non-bacteriostatic 0.9% Sodium Chloride (saline) or sterile Phosphate-Buffered Saline (PBS, pH 7.4). If long-term stock concentration storage is required, sterile Water for Injection (WFI) may be utilized. Gently swirl or invert the vial to achieve full dissolution; high-shear vortexing or vigorous agitation should be avoided to prevent mechanical shearing or aggregation. Reconstituted stock solutions should be aliquoted into single-use polypropylene microtubes to eliminate freeze-thaw degradation cycles.
Prior to reconstitution, lyophilized Cortagen exhibits exceptional stability when stored in climate-controlled environments. For optimal long-term preservation (up to 24 months), dry vials should be stored at $-20^\circ\text{C}$ or $-80^\circ\text{C}$ away from direct ambient light exposure. Desiccant packs should remain inside storage containers to mitigate moisture absorption upon removal from sub-zero freezers.
Once reconstituted into aqueous solution, Cortagen stock solutions should be stored at $2^\circ\text{C}$ to $8^\circ\text{C}$ for immediate use within 3 to 7 days. For extended experimental timelines spanning several weeks, liquid aliquots must be stored at $-80^\circ\text{C}$. Repeated thermal cycling degrades the peptide bonds over time, resulting in fragment formation measurable via analytical HPLC. Follow standard laboratory safety and biosafety protocols for handling research reagents.
Securing consistent research material requires a reliable supply chain partner capable of fulfilling institutional procurement demands. PX1 Research operates centralized synthesis and distribution facilities located in California and Arizona, ensuring rapid order fulfillment across North America. Orders placed before cut-off times ship same-day via expedited carrier channels.
For universities, contract research organizations (CROs), and commercial biotech enterprises requiring high-volume orders, PX1 Research provides streamlined purchasing options through our wholesale program. Institutional buyers benefit from volume tiering, dedicated lot reservation, custom synthesis configurations, and priority technical support from our internal chemical synthesis experts.
What is the primary target application for Cortagen in preclinical research?
Cortagen is supplied strictly as a research compound for in vitro and animal models investigating neurodegenerative pathways, gene expression modulation in cortical neurons, anti-inflammatory mechanisms, and cellular repair under ischemic or oxidative stress.
How is Cortagen's purity verified at PX1 Research?
Every lot of Cortagen undergoes independent third-party analytical testing using RP-HPLC to confirm chromatographic purity (>98%) and ESI-MS to confirm precise molecular mass. Certificates of Analysis are publicly available for every batch.
What are the endotoxin limits for PX1 Research Cortagen?
PX1 Research verifies that all research peptides, including Cortagen, meet strict endotoxin standards (<0.05 EU/mg) using chromogenic assays, ensuring suitability for sensitive cell culture and animal model applications.
What solvent is recommended for reconstituting Cortagen in cell culture assays?
Standard laboratory protocols typically reconstitute lyophilized Cortagen in sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile 0.9% sodium chloride solution under sterile hood conditions.
How does Cortagen compare structurally to Epitalon and Pinealon?
Cortagen is a tetrapeptide (Ala-Glu-Asp-Pro) primarily studied for CNS and cortical gene regulation. Pinealon is a tripeptide (Glu-Asp-Arg) focused on ROS scavenging and hypoxia models, while Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase modulation.
Where does PX1 Research manufacture and ship Cortagen?
PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from distribution hubs in California and Arizona with same-day dispatch for orders placed Monday through Friday.
Can Cortagen be purchased in bulk for institutional accounts?
Yes, academic institutions, biotech firms, and CROs can access bulk pricing, lot reservation, and dedicated account management through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.